Navigation Links
Manzo Pharmaceuticals, LLC Unveils the Unique Health Benefits of Lacto-Freedom Probiotic
Date:2/9/2017

People with lactose sensitivity will now receive some relief as Ken Manzo, the founder of Manzo Pharmaceuticals LLC, unveiled the health benefits of the company’s new and unique patented supplement “Lacto-Freedom Probiotic.” Lactose sensitivity is a common health challenge which results from the inability to properly digest lactose, a sugar found in milk and other milk products. This is caused by the deficiency of lactase, an enzyme in the human body which is normally produced by the cells lining the small intestine.

After consuming food that contains lactose, people with lactose sensitivity regularly experience abdominal pain, bloating, gas, diarrhea, and nausea. The discomfort can range from mild to severe, depending on the quantity of lactose consumed and the tolerance level of the person.

To provide relief to the people with lactose sensitivity, Manzo Pharmaceuticals, LLC., along with Celprogen, Inc., researched, produced, and made available its unique patented supplement “Lacto-Freedom Probiotic.” This nutritional supplement which is specifically designed for people who have difficulty tolerating lactose assists in the digestion of foods containing lactose thereby relieving users from the discomfort that is associated with lactose sensitivity.

As explained by Ken Manzo, “Lacto-Freedom Probiotic is consumed for 7 days and stays in the intestines and produces the enzyme lactase which aids in the digestion of lactose thereby eliminating or greatly reducing the discomfort associated with lactose sensitivity. The use of Lacto-Freedom Probiotic has allowed lactose sensitive people to enjoy milk and other dairy products without experiencing the digestive discomfort resulting in many positive customer reviews.”

Now lactose sensitive people, who have difficulty tolerating dietary lactose, are no longer limited to the two options of either avoiding foods containing lactose or taking lactase supplements at the beginning of every lactose-containing meal. The probiotic is more economical and convenient than taking lactase tablets as the effects of the supplement last for months when consumed only for 7 days.

Click here to see a video on "How Lacto-Freedom Works"

Lacto-Freedom Probiotic:

Taken for only 7 days and effect and relief last for months.
Aids in the digestion of lactose-containing foods.
Patented, clinically tested.
More convenient and more economical than taking lactase tablets or consuming lactose-free foods.

Click here to watch a video on "How Lacto-Freedom Probiotic Works in the Intestines."

For more information about Lactose freedom probiotic and to purchase, visit: LactoFreedom.com

Follow us on Facebook /Manzopharma

About Manzo Pharmaceuticals, LLC
Manzo Pharmaceuticals is a private firm established by Ken Manzo R. Ph., and is located in Pike County, Pennsylvania. Ken is the inventor of the patented Lacto-Freedom Probiotic and co-developed it with Celprogen, Inc., a biotech company in California. Ken Manzo is a licensed pharmacist in New York, New Jersey, and Pennsylvania. For further inquiries contact Ken at manzopharma(at)outlook(dot)com

Read the full story at http://www.prweb.com/releases/2017/02/prweb14055225.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Manzo Pharmaceuticals, LLC Announced That the Name of Their Main Product Lacto-Freedom Was Accepted as a Registered Trademark by the US Patent and Trademark Office
2. Kirk Manzo of The Manzo Group Announces New Affiliation with The John Maxwell Team
3. National Association of Professional Women Inducts Usha R. Patel, Senior Patent Agent at Boehringer Ingelheim Pharmaceuticals, Inc., Into its VIP Woman of the Year Circle
4. National Association of Professional Women Inducts Linda M. Vrasich, M.B.A., DEA Coordinator of Morton Grove Pharmaceuticals, Into its VIP Woman of the Year Circle
5. Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc.
6. National Association of Professional Women Announces Donna Ames, Sr. Manager, Clinical Project Lead at Alexion Pharmaceuticals, a 2014 Professional Woman of the Year
7. BabelBark Unveils BabelVet at NAVC to Help Regional and Independent Veterinary Hospitals Compete in an Ever-Changing Landscape
8. Taza Agua Unveils New Innovative Water Bottles to Enhance K-Cup Drinking Experience
9. Pennsylvania Addiction Treatment Center Unveils New Website on New Domain
10. iaedp™ Unveils Spanish Language Schedule for 2017 Symposium
11. Compass Health Brands Unveils Seven New Pain Management Devices at CES 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2019)... ... February 19, 2019 , ... O’Neil Digital ... release of their enrollment kit solution, called ONEkit™ 2.0. This new tool allows ... and existing customers. ONEkit is integrated with O’Neil’s Omni-channel system, allowing enrollment kits ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... center in the United States and a part of the Prelude Fertility ... the campus of Piedmont Atlanta Hospital. , The only reproductive endocrinology practice on ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... K.J. Kidd, ... her book “Dexascan: Beyond a Missed Opportunity”: an autobiographical work offered to encourage other ... provide early detection. , Kidd shares, “On September 28th of 2013, I spent ...
(Date:2/19/2019)... ... , ... The San Diego Superior Court has entered a judgment approving the ... of a class of approximately 14,100 patients who were admitted in-patient to one of ... 2013, in a class action case (Santana, et al. v. Rady Children’s Hospital – ...
(Date:2/16/2019)... ... February 15, 2019 , ... The Public Health ... which will bring the benefits of national accreditation to the vital records and ... Vital Records and Health Statistics Accreditation Program adds to the already robust ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... ... Contract (number MS11396) has been extended through January 31, 2021. This contract ... and TheraBond® product ranges to be available to Vizient members across the ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... health and wellness industry. The rapid growth of this sector is expected to ... formulas, is one of the major leaders in this space. The company makes ...
(Date:2/19/2019)... ... ... ExceleraRx Corporation announced today that St. Luke’s Health System has joined the ... the state of Idaho. , “We are very pleased to welcome St. ... Corp. “We believe St. Luke’s commitment to expanding and leveraging its pharmacy capabilities to ...
Breaking Medicine Technology: